ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada
· Delayed Price · Currency is CAD 0.7000
-0.0100 (-1.41%)
May 12, 2025, 9:30 AM EDT
ZYUS Life Sciences Revenue
In the year 2024, ZYUS Life Sciences had annual revenue of 481.00K CAD with 37.04% growth. ZYUS Life Sciences had revenue of 126.00K in the quarter ending December 31, 2024, with 29.90% growth.
Revenue
481.00K
Revenue Growth
+37.04%
P/S Ratio
108.21
Revenue / Employee
n/a
Employees
n/a
Market Cap
52.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 481.00K | 130.00K | 37.04% |
| Dec 31, 2023 | 351.00K | 53.00K | 17.79% |
| Dec 31, 2022 | 298.00K | 91.00K | 43.96% |
| Dec 31, 2021 | 207.00K | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.58B |
| Sienna Senior Living | 896.45M |
| Extendicare | 1.47B |
| Trulieve Cannabis | 1.71B |
| Cronos Group | 179.08M |
| WELL Health Technologies | 919.69M |
| Curaleaf Holdings | 1.89B |